Approximately 980,000 tablets of a prescription medicine to treat high blood pressure have been ordered removed from pharmacy shelves, with a full recall to be completed by early August after being found to contain an insufficient amount of a key ingredient, the Food and Drug Administration (FDA) announced Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares close up 1.07%
09/16/2025 01:51 PM - Society
Vietnamese trio investigated for illegal cosmetic surgery in Taichung
09/16/2025 12:51 PM - Society
Tropical storm likely to form near Philippines, path uncertain: Expert
09/16/2025 12:09 PM - Politics
Taiwan condemns Chinese 'wolf warrior diplomacy' in Denmark
09/16/2025 10:55 AM - Business
U.S. dollar lower in Taipei trading
09/16/2025 10:21 AM